PP
AZN icon

Pingora Partners’s AstraZeneca AZN Stock Holding History

Pingora Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7K Hold
125
– – 0.01% 163
2026
Q1 		$24.7K Hold
125
– – 0.01% 162
2025
Q4 		$23K Hold
125
– – 0.01% 160
2025
Q3 		$19.2K Hold
125
– – 0.01% 164
2025
Q2 		$17.5K Hold
125
– – 0.01% 166
2025
Q1 		$18.4K Hold
125
– – 0.01% 167
2024
Q4 		$16.4K Hold
125
– – 0.01% 181
2024
Q3 		$19.5K Hold
125
– – 0.01% 176
2024
Q2 		$19.5K Hold
125
– – 0.01% 173
2024
Q1 		$16.9K Hold
125
– – 0.01% 193
2023
Q4 		$16.8K Buy
+125
New +$16.3K 0.01% 137

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pingora Partners's AZN Position: Q2 2026 in Review

Pingora Partners held its AstraZeneca (AZN) position steady in Q2 2026 at 125 shares worth $23.7K. The position accounts for 0.01% of the portfolio, ranked #163.

Pingora Partners first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $24.7K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Pingora Partners held 125 shares of AstraZeneca worth $23.7K as of Q2 2026.
  • Pingora Partners left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.01% of Pingora Partners's portfolio in Q2 2026, its #163 holding.
  • Pingora Partners first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • Pingora Partners's AstraZeneca position peaked at $24.7K in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.